On the contrary, the CH-associated genetic alterations in the current cohort are characterized primarily by the C>T and C>G mutations (64% of all the mutations) in TET2 and DNMT3A (Figure 2A and C). This evidence concerns the gene DNMT3A and cyclic hematopoiesis.